Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
Markers of Immune Activation and Inflammation Are Associated with Higher Levels of Genetically-Intact HIV in HIV-HBV Co-Infected Individuals.
复制标题
DOI:
10.1128/jvi.00588-22
复制
发表时间:
2022-08-24
影响因子:
5.4
通讯作者:
Palmer, Sarah
中科院分区:
文献类型:
--
作者:
Wang, Xiao Qian;Zerbato, Jennifer M.;Avihingsanon, Anchalee;Fisher, Katie;Schlub, Timothy;Rhodes, Ajantha;Audsley, Jennifer;Singh, Kasha P.;Zhao, Wei;Lewin, Sharon R.;Palmer, Sarah
关键词:
Co-infection with hepatitis B (HBV) and human immunodeficiency virus (HIV) increases overall and liver-related mortality. In order to identify interactions between these two viruses in vivo, full-length HIV proviruses were sequenced from a cohort of HIV-HBV co-infected participants and from a cohort of HIV mono-infected participants recruited from Bangkok, Thailand, both before the initiation of antiretroviral therapy (ART) and after at least 2 years of ART. The co-infected individuals were found to have higher levels of genetically-intact HIV proviruses than did mono-infected individuals pre-therapy. In these co-infected individuals, higher levels of genetically-intact HIV proviruses or proviral genetic-diversity were also associated with higher levels of sCD14 and CXCL10, suggesting that immune activation is linked to more genetically-intact HIV proviruses. Three years of ART decreased the overall level of HIV proviruses, with fewer genetically-intact proviruses being identified in co-infected versus mono-infected individuals. However, ART increased the frequency of certain genetic defects within proviruses and the expansion of identical HIV sequences. IMPORTANCE With the increased availability and efficacy of ART, co-morbidities are now one of the leading causes of death in HIV-positive individuals. One of these co-morbidities is co-infection with HBV. However, co-infections are still relatively understudied, especially in countries where such co-infections are endemic. Furthermore, these countries have different subtypes of HIV circulating than the commonly studied HIV subtype B. We believe that our study serves this understudied niche and provides a novel approach to investigating the impact of HBV co-infection on HIV infection. We examine co-infection at the molecular level in order to investigate indirect associations between the two viruses through their interactions with the immune system. We demonstrate that increased immune inflammation and activation in HBV co-infected individuals is associated with higher HIV viremia and an increased number of genetically-intact HIV proviruses in peripheral blood cells. This leads us to hypothesize that inflammation could be a driver in the increased mortality rate of HIV-HBV co-infected individuals.
登录
查看更多内容
DOI:
10.1097/qad.0b013e32832e463a
发表时间:
2009-09-10
期刊:
AIDS (London, England)
影响因子:
--
作者:
Hoffmann CJ;Seaberg EC;Young S;Witt MD;D'Acunto K;Phair J;Thio CL
通讯作者:
Thio CL
DOI:
10.1073/pnas.1308313110
发表时间:
2013-12-17
影响因子:
11.1
作者:
Josefsson, Lina;von Stockenstrom, Susanne;Palmer, Sarah
通讯作者:
Palmer, Sarah
影响因子:
168.9
作者:
Maartens, Gary;Celum, Connie;Lewin, Sharon R.
通讯作者:
Lewin, Sharon R.
影响因子:
3.8
作者:
Law, WP;Duncombe, CJ;Dore, GJ
通讯作者:
Dore, GJ
影响因子:
6.4
作者:
Crane, Megan;Avihingsanon, Anchalee;Lewin, Sharon R.
通讯作者:
Lewin, Sharon R.